Free tool
Stocks near their 52-week high
We cover 46 companies trading within 5% of their own 52-week high. The median market value in the group is $814.95M. Across the group, the median move over the past trading day is 0.00%. 98% of the 45 with a 200-day average trade above it. Price change over the past year runs from +30.3% to +261.3% across the middle 80 percent of the group, with a median of +96.2%.
Other lists in this group
Table
46 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| TBRG | TruBridge Inc | $393.58M | Small cap | +30.42% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +103.46% |
| EMPG | Empro Group Inc | $143.05M | Small cap | +76.60% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.